[Thrombogenicity and thromboresistance of vessels during postischemic reperfusion].
Vlasov
T D
TD
D000818:Animals; D001120:Arginine / Q000494:pharmacology; D001160:Arterioles / Q000473:pathology / Q000503:physiopathology; D002545:Brain Ischemia / Q000473:pathology / Q000503:physiopathology; D004837:Epinephrine / Q000494:pharmacology; D006614:Hindlimb / Q000098:blood supply; D007421:Intestine, Small / Q000098:blood supply; D008297:Male; D008833:Microcirculation; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000473:pathology / Q000503:physiopathology; D009569:Nitric Oxide / Q000096:biosynthesis; D051381:Rats; D015427:Reperfusion Injury / Q000150:complications / Q000473:pathology* / Q000503:physiopathology; D013152:Splanchnic Circulation; D013927:Thrombosis / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014699:Venules / Q000473:pathology / Q000503:physiopathology
D014662:Vasoconstrictor Agents; D009569:Nitric Oxide; D001120:Arginine; D004837:Epinephrine